The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
Open accessAbstract
Both type I and II interferons (IFNs) have been implicated in the pathogenesis of Sjogren's syndrome (SS). We aimed to explore the contribution of type I and II IFN signatures in the generation of distinct SS clinical phenotypes including lymphoma development. Peripheral blood (PB) from SS patients (n=31), SS patients complicated by lymphoma (n=13) and healthy controls (HC, n=30) were subjected to real-time PCR for 3 interferon inducible genes (IFIGs) preferentially induced by type I IFN, 2 IFIGs preferentially induced by IFNγ as well as for IFNα and IFNγ genes. The same analysis was performed in minor salivary gland tissues (MSG) derived from 31 SS patients, 10 SS-lymphoma patients and 17 sicca controls (SC). In PB and MSG tissues, overexpression of both type I and type II IFIGs was observed in SS patients versus HC and SC, respectively, with a predominance of type I IFN signature in PB and a type II IFN signature in MSG tissues. In SS-lymphoma MSG tissues, lower IFNα, but higher IFNγ and type II IFIG transcripts compared to both SS and SC were observed. In receiver operating characteristic curve analysis, IFNγ/IFNα mRNA ratio in MSG tissues showed the best discrimination for lymphoma development. Discrete expression patterns of type I and II IFN signatures might be related to distinct SS clinical phenotypes. Additionally, IFNγ/IFNα mRNA ratio in diagnostic salivary gland biopsies is proposed as a novel histopathological biomarker for the prediction of in situ lymphoma development in the setting of SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Hu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928
The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis
Zintzaras, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.20.2337 · Cited by 771
Gottenberg, J.-E., Cagnard, N., Lucchesi, C., Letourneur, F., Mistou, S., Lazure, T., Jacques, S., Ba, N., Ittah, M., Lepajolec, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510837103 · Cited by 611
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome
Mariette, X., Roux, S., Zhang, J., Bengoufa, D., Lavie, F., Zhou, T., & Kimberly, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.168 · Cited by 554
Ioannidis, J. P. A., Vassiliou, V. A., & Moutsopoulos, H. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10221 · Cited by 483
Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus
Kirou, K. A., Lee, C., George, S., Louca, K., Papagiannis, I. G., Peterson, M. G. E., Ly, N., Woodward, R. N., Fry, K. E., Lau, A. Y., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20798 · Cited by 418
Self-citationInterferon-γ: A historical perspective
Billiau, A., & Matthys, P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.004 · Cited by 412
Brkić, Z., Maria, N. I., van Helden-Meeuwsen, C. G., van de Merwe, J. P., van Daele, P. L. A., Dalm, V. A. S. H., Wildenberg, M. E., Beumer, W., Drexhage, H. A., & Versnel, M. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201381 · Cited by 318
Hua, J., Kirou, K., Lee, C., & Crow, M. K. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21890 · Cited by 317
Self-citation
Cited by
EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies
Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216114 · Cited by 732
Type I interferon in rheumatic diseases
Muskardin, T. L. W., & Niewold, T. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.31 · Cited by 308
Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis
Verstappen, G. M., Pringle, S., Bootsma, H., & Kroese, F. G. M. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00605-2 · Cited by 298
Mavragani, C. P., Nezos, A., Sagalovskiy, I., Seshan, S., Kirou, K. A., & Crow, M. K. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.004 · Cited by 85
Self-citation
Metadata
- Authors
- Nezos, A., Gravani, F., Tassidou, A., Kapsogeorgou, E. K., Voulgarelis, M., Koutsilieris, M., Crow, M. K., & Mavragani, C. P.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 63
- Pages
- 47-58
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W896811953
- Cited by
- 259
- References
- 44
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. https://app.cochat.ai/papers/10.1016/j.jaut.2015.07.002
- The paper
- Nezos, A., Gravani, F., Tassidou, A., Kapsogeorgou, E. K., Voulgarelis, M., Koutsilieris, M., Crow, M. K., & Mavragani, C. P. (2015). Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. Journal of Autoimmunity. https://doi.org/10.1016/j.jaut.2015.07.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
